ERBB2 and cancer: Among the grand range of extracellular receptors usually targeted in cancer therapy, the Human Epidermal Growth Factor Receptor 2 (EGFR2, also known as ERBB2 or HER2) is largely investigated, since its aberrant expression correlates with different malignancies.